Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis.

In sepsis there is extensive apoptosis of lymphocytes, which may be beneficial by down-regulating the accompanying inflammation. Alternatively, apoptosis may be detrimental by impairing host defense. We studied whether Bcl-2, a potent antiapoptotic protein, could prevent lymphocyte apoptosis in a clinically relevant model of sepsis. Transgenic mice in which Bcl-2 was overexpressed in T cells had complete protection against sepsis-induced T lymphocyte apoptosis in thymus and spleen. Surprisingly, there was also a decrease in splenic B cell apoptosis in septic Bcl-2 overexpressors compared with septic HeJ and HeOuJ mice. There were marked increases in TNF-alpha, IL-1beta, and IL-10 in thymic tissue in sepsis in the three species of mice, and the increase in TNF-alpha and IL-10 in HeOuJ mice was greater than that in Bcl-2 mice. Mitotracker, a mitochondrial membrane potential indicator, demonstrated a sepsis-induced loss of membrane potential in T cells in HeJ and HeOuJ mice but not in Bcl-2 mice. Importantly, Bcl-2 overexpressors also had improved survival in sepsis. To investigate the potential impact of loss of lymphocytes on survival in sepsis, Rag-1-/- mice, which are totally deficient in mature T and B cells, were also studied. Rag-1-/- mice had decreased survival compared with immunologically normal mice with sepsis. We conclude that overexpression of Bcl-2 provides protection against cell death in sepsis. Lymphocyte death may be detrimental in sepsis by compromising host defense.

[1]  R. Hotchkiss,et al.  PYRROLIDINE DITHIOCARBAMATE ACTIVATES THE HEAT SHOCK RESPONSE AND THEREBY INDUCES APOPTOSIS IN PRIMED ENDOTHELIAL CELLS , 1998, Shock.

[2]  Z. Wang,et al.  Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations. , 1998, Journal of immunology.

[3]  G. Kroemer,et al.  Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins , 1998, Oncogene.

[4]  G. Kroemer,et al.  The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins , 1998, The Journal of experimental medicine.

[5]  E. Deitch.  ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.

[6]  A. Fattorossi,et al.  Is chloromethyl-X-rosamine useful in measuring mitochondrial transmembrane potential? , 1998, Cytometry.

[7]  C. Cordon-Cardo,et al.  Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation , 1997, The Journal of experimental medicine.

[8]  R. Hotchkiss,et al.  Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. , 1997, Critical care medicine.

[9]  S. Korsmeyer,et al.  Bcl-2 and Bax function independently to regulate cell death , 1997, Nature Genetics.

[10]  Guido Kroemer,et al.  The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[11]  Kevin A. Roth,et al.  bax Deficiency Prevents the Increased Cell Death of Immature Neurons in bcl-x-Deficient Mice , 1997, The Journal of Neuroscience.

[12]  R. Hotchkiss,et al.  CECAL LIGATION AND PUNCTURE (CLP) INDUCES APOPTOSIS IN THYMUS, SPLEEN, LUNG, AND GUT BY AN ENDOTOXIN AND TNF‐INDEPENDENT PATHWAY , 1997, Shock.

[13]  G. Linette,et al.  Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[15]  I. Chaudry,et al.  Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. , 1996, Blood.

[16]  Hotchkiss Rs,et al.  Calcium: a regulator of the inflammatory response in endotoxemia and sepsis. , 1996 .

[17]  S. Korsmeyer,et al.  Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.

[18]  R. Hotchkiss,et al.  Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin. , 1995, Shock.

[19]  I. Chaudry,et al.  THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS: CONTROL BY CORTICOSTEROIDS BUT NOT TUMOR NECROSIS FACTOR , 1995, Shock.

[20]  R. B. Chapin,et al.  The role of programmed cell death (apoptosis) in thymic involution following sepsis. , 1994, Archives of surgery.

[21]  Y. S. Lin,et al.  Sepsis-induced apoptosis of the thymocytes in mice. , 1994, Journal of immunology.

[22]  R. Stone.  Search for sepsis drugs goes on despite past failures. , 1994, Science.

[23]  Z. Oltvai,et al.  Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. , 1993, Seminars in cancer biology.

[24]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[25]  D. Bredesen,et al.  bcl-2 inhibits death of central neural cells induced by multiple agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[27]  I. Bedrosian,et al.  Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays , 1991 .

[28]  S. Korsmeyer,et al.  bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.

[29]  C. Haslett,et al.  Neutrophil apoptosis and clearance from neonatal lungs , 1991, The Lancet.

[30]  W. Fiers,et al.  Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. , 1991, The American journal of pathology.

[31]  L. Hagberg,et al.  Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections. , 1985, Journal of immunology.